Search

everythinglearnresearchcommunity

for

Search:↓

Low-power laser therapy is an effective, side-effect-free treatment that speeds up hair regrowth and crural ulcer healing.

Hyperbaric oxygen therapy improves hair growth and quality of life in androgenic alopecia patients.

Degenerative changes in the lower cervical spine are common in patients with abnormal scalp sensations, with some improvement seen using pain medication and physical therapy.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Stem cell therapy from hair follicles effectively treats advanced hair loss with minimal side effects.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Taking metformin with intense pulsed light therapy improves hair removal for women with PCOS.

Combining medication for dyslipidemia and insulin resistance with basic therapy improves outcomes for alopecia areata with metabolic syndrome.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Patients with ichthyosis often experience symptoms similar to psoriasis and atopic dermatitis, suggesting that targeted therapies could improve their condition.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Low iron levels may be linked to some types of hair loss in women.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Levetiracetam may cause hair loss, which can potentially reverse with lower doses or stopping the drug.

People with Mucopolysaccharidoses often have skin problems like thick skin and extra hair, and recognizing these can help diagnose and treat the condition early.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Zinc supplements increased zinc levels in some hair loss patients but didn't significantly improve hair growth.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.